Purimox (Amoxicillin Trihydrate) manufactured by DSM Anti-Infectives (DAI) at its Toansa India plant has received European Certificate of Suitability. With this, DAI India will be able to sell Purimox to customers who intend to export their finished formulations to European as well as observer countries. Purimox is DSM's brand name for Amoxicillin Trihydrate. Purimox is manufactured via an eco-friendly enzymatic process using no organic solvents, thereby resulting into an API of very high purity, which gives benefits to both, customers and the patients.

"This milestone revalidates our efforts to bring world class products manufactured with leading edge technology to all our customers in Asia Pacific, Middle East and Africa," commented Bharath Sesha, vice-president, DSM Anti-Infectives.

DSM Pure Actives is the umbrella brand under which, DSM is manufacturing APIs using green (enzymatic) technology, thereby leading to positive impact on environment and on the patient's health. Other APIs under this category, which DSM is manufacturing at its various locations across the globe, are Ampicillin (Puricillin), Cefalexin (Purilex) and Cefadroxil (Puridrox).

DSM Anti-Infectives is the world's leading supplier of active pharmaceutical ingredients such as Amoxicillin, Ampicillin, Cefalexin and Cefadroxil, the worlds most widely used broad spectrum antibiotics for combating bacterial infections. Its product portfolio also includes Clavulanic Acid, Nystatin, Penicillin, Penicillin Intermediates (6-APA and 7-ADCA), industrial enzymes and side chains. The company is headquartered in Delft, the Netherlands, and has a global presence with manufacturing facilities in Europe, Africa, Mexico, China and India and sales offices across the globe.

Royal DSM N V creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life.